US$ 24.22
retatrutide clinical study The drug is manufactured by Eli Lilly and is not FDA approved, however, one person gained access to the prescription through a program that approves experimental treatments for patients traditionally suffering Retatrutide Phase 1 Trials |
Description
Interestingly, while atrophy is similar during immobilization, GLP-1 medicines have a distinct effect on the muscle proteome compared to calorie restriction

If your levels are too low, you can't donate

Several companies, like Regeneron, are working on muscle-sparing (or even gaining) drugs to pair up with GLP-1s

Novo Nordisk have however since discontinued their research in triple agonists, citing their intention to focus on semaglutide
2012;35:e76